Research & Development

Publications

Prevalence and Incidence of Patients with Paroxysmal Supraventricular Tachycardia in the United States

This study utilized claims data from both Medicare and private insurers to estimate the treated prevalence and incidence of PSVT in the U.S. over a 9-year period.

Analysis of Clinical Outcomes in the NODE-301 Trial

Etripamil Nasal Spray Relieves Symptoms and Reduces Emergency Room Interventions in Patients with Paroxysmal Supraventricular Tachycardia (PSVT).

Trends in Healthcare Resource Use and Expenditures in Patients with Newly Diagnosed Paroxysmal Supraventricular Tachycardia in the United States. 2021.

This study explored the cost of health care spending in patients under the age of 65 three years before and three years after a PSVT diagnosis.